• Canada

in page functions
  • Canada flag

  • Proceeds to Gavi from donor contributions & pledges (2016-2020) as of 31 March 2018

     

     

    Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.

  • Contributions and pledges over time (US$ millions)

     

    Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
     

    Notes:
    Direct Contributions (including Matching Fund)
    Received contributions: non-US$ contributions for 2000-2017 and Q1 2018 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014, 2015, 2016, 2017 and Q1 2018, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.

    Future contributions: non-US$ Direct Contribution and Matching Fund pledges for Q2 - Q4 2018 and years 2019 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 31 March 2018 or using the rates applicable to any hedge agreement in place.

    IFFIm contributions
    Received contributions: non-US$ contributions for 2000-2017 and Q1 2018 are expressed in US$ equivalents as confirmed by the IBRD (World Bank).

    Future contributions: non-US$ contributions for Q2 - Q4 2018 and years 2019 and beyond are expressed in US$ equivalents as follows:

    • Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements.
    • Where the contribution agreement has not yet been signed: contributions are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 31 March 2018.
    • These contributions have not been reduced by a notional 3% provision to allow for any potential reduction arising from the High Level Financing Condition of the IFFIm Finance Framework Agreement.

     

  • Funding history

    Canada is a recognized anchor donor of the Vaccine Alliance, leading global efforts to advance gender equality and women’s empowerment and reduce the burden of infectious diseases through vaccination. Gavi’s immunisation strategy is further supported by Canada’s 2018 G7 Presidency priorities: immunisation impacts on girls and boys, families, and economies. This approach is foundational to equitable growth and jobs, mitigating the health impacts of climate change, and building resilient systems and vaccine stockpiles to both prevent and respond to global health security threats.

    Since 2002 Canada has invested over CAD 1 billion through Gavi and is a founding donor of the Pneumococcal Advance Market Commitment (AMC). Between 2002 and 2010 Canada contributed USD 277 million to Gavi including USD 152 million (CAD 188 million) in direct contributions and USD 125 million through the AMC. Canada’s total commitment to the AMC is USD 200 million.

    In 2011, as part of Gavi’s first Replenishment, Canada pledged CAD 65 million in direct contributions to Gavi for 2011-2015.

    In 2013, Canada confirmed a direct grant of CAD 20 million for Gavi’s Measles Supplementary Immunisation Activities (MSIA) programme.

    In 2014, Canada contributed two additional CAD 20 million grants, respectively to support the Vaccine Alliance’s Immunisation Supply Chain Strategy and francophone countries’ immunisation activities – these contributions were made in line with the Muskoka Initiative.

    In the lead-up to Gavi’s second Replenishment, Canada pledged CAD 500 million to Gavi to support immunization in development countries for the period 2016-2020, more than doubling the nation’s previous total contributions. Building upon this commitment a further CAD 20 million was pledged in January 2015 and has been allocated to Gavi’s innovation accelerator, INFUSE, for Francophone Africa. This commitment makes Canada the leading donor to INFUSE- underscoring the administration’s leadership in innovation.

    Canadian leadership in immunisation extends beyond Gavi and includes contributions to the Canadian International Immunisation Initiative (C-III) between 1998 and 2013 and, as a top-five donor to the Global Polio Eradication Initiative (GPEI) since 1988.

    Contributions and pledges in total:

    • Direct funding (2002-2015): USD 271.3 million;
    • AMC (2009-2014): USD 200 million;
    • New pledge (2016-2020): CAD 520 million (USD 409.7 million) in direct funding.
close icon

modal window here